BCR/ABL1 Quant Test regulatory update
Asuragen received CE Mark approval in Europe for its BCR/ABL1 Quant Test to aid in the assessment of complete cytogenetic response (CCyR), major molecular response (MMR), minimal residual disease and relapse in Philadelphia chromosome-positive chronic...
